Oregon's Medicaid program now covers puberty-suppression drugs

Oregon Medicaid covers puberty-suppression drugs

(Image credit: Twitter/@NPRHealth)

published 6 April 2015

A handful of states cover medical costs for transgender Medicaid recipients, but Oregon is the only one that uses Medicaid funds to help pre-transgender kids delay puberty. Temporarily suppressing puberty requires a shot of a drug called Lupron every three months, at a cost of about $7,500 per injection, but "people with gender dysphoria that did not receive treatment had a much higher rate of hospitalizations or ER visits or doctors visits for depression and anxiety, and they had a pretty significantly high suicide rate," Dr. Ariel Smits tells NPR.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Explore More

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.

Subscribe to The Week

Sign up for The Week's Free Newsletters

Sign up for Today's Best Articles in your inbox